"The US Food and Drug Administration (FDA) has approved lenvatinib (Lenvima, Eisai), in combination with everolimus, for the treatment of patients with advanced renal cell carcinoma who were previously treated with an anti-angiogenic ther"...
Administration should not be made in exposed cavities or where there is evidence of loculation unless the extent of loculation is determined.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 6/17/2009
Additional Phosphocol Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.